Related Experiment Video

Updated: Apr 6, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

Ukhyun Jo1, Hyungjin Kim1

  • 1Department of Pharmacological Sciences, Stony Brook University, New York 11794, USA.

Molecules and Cells
|July 22, 2015
PubMed

Insights

Faulty DNA repair causes genome instability and cancer. Understanding the Fanconi anemia (FA) pathway offers new therapeutic strategies by targeting cancer cells with defective DNA interstrand cross-link (ICL) repair.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genome instability, often due to DNA repair defects, is a key driver of cancer.
  • Targeting cancer-specific DNA repair alterations can lead to synthetic lethality or enhance chemotherapy/radiotherapy efficacy.
  • Fanconi anemia (FA) research has illuminated the role of DNA repair defects in tumorigenesis.

Purpose of the Study:

  • To review recent advances in understanding the Fanconi anemia (FA) pathway regulation.
  • To explore the therapeutic potential of targeting deregulated DNA interstrand cross-link (ICL) repair in cancer.

Main Methods:

  • Review of current literature on FA pathway signaling and cancer therapeutics.
  • Analysis of the role of ubiquitin-mediated signaling in FA pathway activation.

Main Results:

  • The FA pathway is crucial for resolving stalled replication forks caused by DNA interstrand cross-links (ICLs).
  • Knowledge of FA pathway activation provides novel therapeutic avenues for cancer treatment.
  • Targeting specific DNA repair defects in cancer holds promise for tailored therapies.

Conclusions:

  • Advances in understanding FA pathway regulation offer opportunities for developing targeted cancer therapies.
  • Exploiting defective DNA ICL repair in tumors can be a viable strategy for cancer treatment.
Keywords:
DNA interstrand cross-linkDNA repairFanconi anemiacancer therapeuticsubiquitin signaling

More Related Videos

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

6.8K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K